US 2017/0319604 A1Published application

Thyroid hormone receptor agonist and use thereof

AssigneeMetabasis Therapeutics, Inc.

InventorsMark Erion, Hongjian Jiang, Serge Henri Boyer

Life of this patent

Estimating the term…

Abstract

A thyroid hormone receptor agonist and its use in the treatment of a disease associated thyroid hormone receptor beta are described. The compound can be effective in lowering cholesterol with minimum or no adverse effects on the heart or thyroid hormone axis.

Claims20

Dependent claims

A compound having a structure:

or a pharmaceutically acceptable salt thereof

Dependencies are inferred from the claim text.

Facts

Application: 15/492,398Filed 20 Apr 2017
Priority: 22 Apr 2016
Published: 9 Nov 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification20 codes

A61K 31/661
Phosphorus compounds: phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61P 3/00
Drugs for disorders of the metabolism

Family

Application62/326,392Us provisional application · filed 22 Apr 2016
US 2017/0319604 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results